SCHEMBL4033332

SCHEMBL4033332

CC(=O)Nc1ccc2c(c1)C(c1cccnc1)=CC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
CYP11B1 P15538 1/20 0.50
CYP11B2 P19099 1/20 0.50
HSD17B10 Q99714 1/20 0.50
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
ATR Q13535 3/20 0.47
ABL1 P00519 1/20 0.46
PDGFRB P09619 1/20 0.46
BCR P11274 1/20 0.46
PDGFRA P16234 1/20 0.46
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP17A1 P05093 1/20 0.46
AAK1 Q2M2I8 1/20 0.44
CYP1A2 P05177 2/20 0.43
ADRA2A P08913 1/20 0.43
MAOA P21397 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11222723 0.74 CNR1 (0.64) ALDH1A1HPGDCYP11B1CYP11B2HSD17B10
SCHEMBL29611891 0.73 NPC1 (0.65) ALDH1A1HPGDHSD17B10NPC1RAB9A
SCHEMBL11192637 0.73 NPC1 (0.65) ALDH1A1HPGDHSD17B10NPC1RAB9A
SCHEMBL6985231 0.72 NPC1 (0.55) ALDH1A1HPGDCYP11B1CYP11B2HSD17B10
SCHEMBL29602550 0.68 RAB9A (0.65) ALDH1A1CYP11B2HSD17B10NPC1RAB9A
SCHEMBL49506 0.68 RAB9A (0.65) ALDH1A1CYP11B2HSD17B10NPC1RAB9A
SCHEMBL24892502 0.67 AAK1 (0.49) ALDH1A1HPGDCYP11B1CYP11B2HSD17B10
SCHEMBL19706697 0.67 ALDH1A1 (0.53) ALDH1A1HPGDCYP11B1CYP11B2HSD17B10
SCHEMBL1570408 0.67 HPGD (0.53) ALDH1A1HPGDCYP11B1CYP11B2HSD17B10
SCHEMBL6983318 0.67 NPC1 (0.51) ALDH1A1HPGDCYP11B1CYP11B2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071668-B1 5-AMINOINDENO[1,2-C]PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2009-06-03 EP disclosed